Anti-rejection drug plus immunotherapy could change the lives of kidney transplant patients with cancer

Adding immunotherapy to standard anti-rejection medication could change the lives of thousands of kidney transplant patients with incurable cancer, as new research shows it can reduce this risk of organ rejection and eliminate cancer in a quarter of patients.